Anti-GTF2F1 monoclonal antibody

Pre-made anti-GTF2F1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GTF2F1/GTF2F1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2533-Ab-1/ GM-Tg-hg-IP2533-Ab-2Anti-Human GTF2F1 monoclonal antibodyHuman
GM-Tg-rg-IP2533-Ab-1/ GM-Tg-rg-IP2533-Ab-2Anti-Rat GTF2F1 monoclonal antibodyRat
GM-Tg-mg-IP2533-Ab-1/ GM-Tg-mg-IP2533-Ab-2Anti-Mouse GTF2F1 monoclonal antibodyMouse
GM-Tg-cynog-IP2533-Ab-1/ GM-Tg-cynog-IP2533-Ab-2Anti-Cynomolgus/ Rhesus macaque GTF2F1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2533-Ab-1/ GM-Tg-felg-IP2533-Ab-2Anti-Feline GTF2F1 monoclonal antibodyFeline
GM-Tg-cang-IP2533-Ab-1/ GM-Tg-cang-IP2533-Ab-2Anti-Canine GTF2F1 monoclonal antibodyCanine
GM-Tg-bovg-IP2533-Ab-1/ GM-Tg-bovg-IP2533-Ab-2Anti-Bovine GTF2F1 monoclonal antibodyBovine
GM-Tg-equg-IP2533-Ab-1/ GM-Tg-equg-IP2533-Ab-2Anti-Equine GTF2F1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2533-Ab-1/ GM-Tg-hg-IP2533-Ab-2; GM-Tg-rg-IP2533-Ab-1/ GM-Tg-rg-IP2533-Ab-2;
GM-Tg-mg-IP2533-Ab-1/ GM-Tg-mg-IP2533-Ab-2; GM-Tg-cynog-IP2533-Ab-1/ GM-Tg-cynog-IP2533-Ab-2;
GM-Tg-felg-IP2533-Ab-1/ GM-Tg-felg-IP2533-Ab-2; GM-Tg-cang-IP2533-Ab-1/ GM-Tg-cang-IP2533-Ab-2;
GM-Tg-bovg-IP2533-Ab-1/ GM-Tg-bovg-IP2533-Ab-2; GM-Tg-equg-IP2533-Ab-1/ GM-Tg-equg-IP2533-Ab-2
Products NameAnti-GTF2F1 monoclonal antibody
Formatmab
Target NameGTF2F1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GTF2F1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2533-Ag-1Recombinant multi-species T2FA/ GTF2F1/ BTF4 protein
    ORF Viral VectorvGMAP000505Human GTF2F1 Adenovirus particle
    ORF Viral VectorpGMAP000505Human GTF2F1 Adenovirus plasmid


    Target information

    Target IDGM-IP2533
    Target NameGTF2F1
    Gene ID2962,98053,316123,699221,476731,101095797,505702,100065544
    Gene Symbol and Synonyms2810405L04Rik,BTF4,GTF2F1,RAP74,TF2F1,TFIIF
    Uniprot AccessionP35269,Q6AY96,Q5EA53
    Uniprot Entry NameT2FA_HUMAN,T2FA_RAT,T2FA_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125651
    Target ClassificationN/A

    The target: GTF2F1, gene name: GTF2F1, also named as BTF4, RAP74, TF2F1, TFIIF. Enables several functions, including RNA polymerase II general transcription initiation factor activity; phosphatase activator activity; and promoter-specific chromatin binding activity. Involved in several processes, including positive regulation of transcription by RNA polymerase II; response to virus; and transcription initiation from RNA polymerase II promoter. Located in cell junction and nucleoplasm. Part of transcription factor TFIID complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.